![Kyle Steiger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kyle Steiger
Corporate Officer/Principal presso
VALEO PHARMA INC.
Profilo
Kyle Steiger currently works at Valeo Pharma, Inc., as Chief Commercial Officer & Senior Vice President from 2022.
Mr. Steiger also formerly worked at Novartis Pharmaceuticals Canada, Inc., as VP-Ophthalmology, Primary Care & Franchise and Ashfield Healthcare Canada, Inc., as Vice President-Commercial Services.
Mr. Steiger received his undergraduate degree from Brock University.
Posizioni attive di Kyle Steiger
| Società | Posizione | Inizio |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 30/08/2022 |
Precedenti posizioni note di Kyle Steiger
| Società | Posizione | Fine |
|---|---|---|
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Ashfield Healthcare Canada, Inc.
 Ashfield Healthcare Canada, Inc. Part of CD&R Artemis Holdco 2 Ltd., Ashfield Healthcare Canada, Inc. is a life sciences partner operating under the brand Inizio, specializing in integrated, technology-enabled solutions for pharmaceutical and biotech companies across the clinical development and commercialization lifecycle. The company is based in Pointe-Claire, Canada. The Canadian company was formed through the merger of Ashfield and Huntsworth and comprises five specialized business units: Ignite (strategy, transformation, and insights), Medical (medical affairs and scientific communications), Evoke (marketing and communications), Engage (strategic commercial and creative engagement), and Biotech (personalized biotech solutions). Ashfield Healthcare Canada leverages proprietary AI platforms combined with human expertise to optimize product launch, market access, omnichannel engagement, and real-world evidence generation. | Corporate Officer/Principal | - |
Formazione di Kyle Steiger
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
25
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Brock University
 Brock University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Valeo Pharma, Inc.
 Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
Ashfield Healthcare Canada, Inc.
Ashfield Healthcare Canada, Inc. Part of CD&R Artemis Holdco 2 Ltd., Ashfield Healthcare Canada, Inc. is a life sciences partner operating under the brand Inizio, specializing in integrated, technology-enabled solutions for pharmaceutical and biotech companies across the clinical development and commercialization lifecycle. The company is based in Pointe-Claire, Canada. The Canadian company was formed through the merger of Ashfield and Huntsworth and comprises five specialized business units: Ignite (strategy, transformation, and insights), Medical (medical affairs and scientific communications), Evoke (marketing and communications), Engage (strategic commercial and creative engagement), and Biotech (personalized biotech solutions). Ashfield Healthcare Canada leverages proprietary AI platforms combined with human expertise to optimize product launch, market access, omnichannel engagement, and real-world evidence generation. |
